RMD
Price
$198.04
Change
+$1.72 (+0.88%)
Updated
Mar 28, 6:59 PM EST
28 days until earnings call
TRIB
Price
$1.98
Change
-$0.04 (-1.98%)
Updated
Mar 28, 2:27 PM EST
40 days until earnings call
Ad is loading...

RMD vs TRIB ᐉ Comparison: Which is Better to Invest?

Header iconRMD vs TRIB Comparison
Open Charts RMD vs TRIBBanner chart's image
ResMed
Price$198.04
Change+$1.72 (+0.88%)
Volume$133.88K
CapitalizationN/A
Trinity Biotech
Price$1.98
Change-$0.04 (-1.98%)
Volume$2.8K
CapitalizationN/A
View a ticker or compare two or three
RMD vs TRIB Comparison Chart

Loading...

RMDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TRIBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
RMD vs. TRIB commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMD is a Buy and TRIB is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (RMD: $198.04 vs. TRIB: $1.98)
Brand notoriety: RMD and TRIB are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: RMD: 13% vs. TRIB: 10%
Market capitalization -- RMD: $28.88B vs. TRIB: $15.13M
RMD [@Medical Specialties] is valued at $28.88B. TRIB’s [@Medical Specialties] market capitalization is $15.13M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RMD’s FA Score shows that 1 FA rating(s) are green whileTRIB’s FA Score has 1 green FA rating(s).

  • RMD’s FA Score: 1 green, 4 red.
  • TRIB’s FA Score: 1 green, 4 red.
According to our system of comparison, RMD is a better buy in the long-term than TRIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RMD’s TA Score shows that 5 TA indicator(s) are bullish while TRIB’s TA Score has 4 bullish TA indicator(s).

  • RMD’s TA Score: 5 bullish, 4 bearish.
  • TRIB’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, RMD is a better buy in the short-term than TRIB.

Price Growth

RMD (@Medical Specialties) experienced а +2.22% price change this week, while TRIB (@Medical Specialties) price change was -10.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.98%. For the same industry, the average monthly price growth was -0.07%, and the average quarterly price growth was +4.49%.

Reported Earning Dates

RMD is expected to report earnings on Apr 25, 2024.

TRIB is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Medical Specialties (+0.98% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for RMD with price predictions.
OPEN
A.I.dvisor published
a Summary for TRIB with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
RMD($28.9B) has a higher market cap than TRIB($15.1M). TRIB (33.00) and RMD (32.50) have similar P/E ratio . RMD YTD gains are higher at: 15.417 vs. TRIB (-7.692). RMD has higher annual earnings (EBITDA): 1.43B vs. TRIB (-26.34M). RMD has more cash in the bank: 210M vs. TRIB (6.58M). TRIB has less debt than RMD: TRIB (67.3M) vs RMD (1.39B). RMD has higher revenues than TRIB: RMD (4.5B) vs TRIB (71.4M).
RMDTRIBRMD / TRIB
Capitalization28.9B15.1M191,391%
EBITDA1.43B-26.34M-5,429%
Gain YTD15.417-7.692-200%
P/E Ratio32.5033.0098%
Revenue4.5B71.4M6,308%
Total Cash210M6.58M3,192%
Total Debt1.39B67.3M2,067%
FUNDAMENTALS RATINGS
RMD vs TRIB: Fundamental Ratings
RMD
TRIB
OUTLOOK RATING
1..100
1167
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
70
Overvalued
PROFIT vs RISK RATING
1..100
45100
SMR RATING
1..100
45100
PRICE GROWTH RATING
1..100
4579
P/E GROWTH RATING
1..100
782
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RMD's Valuation (16) in the Medical Specialties industry is somewhat better than the same rating for TRIB (70). This means that RMD’s stock grew somewhat faster than TRIB’s over the last 12 months.

RMD's Profit vs Risk Rating (45) in the Medical Specialties industry is somewhat better than the same rating for TRIB (100). This means that RMD’s stock grew somewhat faster than TRIB’s over the last 12 months.

RMD's SMR Rating (45) in the Medical Specialties industry is somewhat better than the same rating for TRIB (100). This means that RMD’s stock grew somewhat faster than TRIB’s over the last 12 months.

RMD's Price Growth Rating (45) in the Medical Specialties industry is somewhat better than the same rating for TRIB (79). This means that RMD’s stock grew somewhat faster than TRIB’s over the last 12 months.

TRIB's P/E Growth Rating (2) in the Medical Specialties industry is significantly better than the same rating for RMD (78). This means that TRIB’s stock grew significantly faster than RMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RMDTRIB
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
52%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 14 days ago
57%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
42%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
RMDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
TRIBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NMG2.170.05
+2.36%
Nouveau Monde Graphite
BLFS18.460.36
+1.99%
BioLife Solutions
AZTA59.431.04
+1.78%
Azenta
GPC155.192.66
+1.74%
Genuine Parts Company
STRR0.89N/A
+0.44%
Star Equity Holdings

TRIB and

Correlation & Price change

A.I.dvisor tells us that TRIB and NVRO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TRIB and NVRO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRIB
1D Price
Change %
TRIB100%
-1.98%
NVRO - TRIB
31%
Poorly correlated
+6.26%
RGEN - TRIB
28%
Poorly correlated
+0.47%
NVCR - TRIB
26%
Poorly correlated
+11.86%
CODX - TRIB
24%
Poorly correlated
-0.45%
UFPT - TRIB
23%
Poorly correlated
+5.01%
More